Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ELPW vs WOK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ELPW Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 5–2 Matrix Metrics)

ELPW Overall Winner 6-Pillar Tally: ELPW 2 – 2 WOK (2 Tie) Matrix Metrics: ELPW 5 – 2 WOK

As of Nov 16, 2026, Elong Power Holding Limited Class A (ELPW) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). ELPW carries a Unified Composite Score of 50.4/100 (HOLD) at $0.91 (N/M Forward P/E, -40.6% operating margin), whereas WOK carries 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin).

  • Technical & Structure Timing Caution: ELPW is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.0); meanwhile WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ELPW vs WOK
ELPW NASDAQ Head-to-Head Winner
Elong Power Holding Limited Class A Ordinary Shares
Miscellaneous Electrical Machinery, Equipment & Supplies
$0.91
-11.64% 1D
Market Cap $2.8M
TTM Revenue $4.9M
Forward P/E N/M
Beta / 30D Vol -70.48β · 220% Vol
Unified Composite Score
50.4 / 100 HOLD
Tech 45.0 Fund 55.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -24.4%), weak momentum, RSI 26
RSI-14: 26.0 · SMA20: $1.95 · SMA50: $2.40
WOK NASDAQ
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.23
+2.5% 1D
Market Cap $5.4M
TTM Revenue $11M
Forward P/E N/M
Beta / 30D Vol 38.49β · 153% Vol
Unified Composite Score
25.6 / 100 SELL
Tech 5.0 Fund 39.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.1 · SMA20: $1.13 · SMA50: $1.47

6-Pillar Scorecard Institutional Category Breakdown (ELPW 2 – 2 WOK)

Columns: Metric · ELPW · WOK
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.6x 0.5x
2. Growth & Scale ELPW
Revenue Growth (YoY) +14977.5% +19.1%
Earnings Growth (YoY) +0.0% -95.0%
TTM Revenue (USD) $4.9M $11M
Market Cap $2.8M $5.4M
3. Profitability & Quality ELPW
Gross Margin 1.8% 17.0%
Operating Margin -40.6% -41.7%
Net Profit Margin 356.3% -41.9%
Return on Equity (ROE) 0.0% -19.2%
4. Balance Sheet & Cash Flow WOK
Cash Generation (TTM) -$2.8M EBITDA -$3.4M EBITDA
Cash Flow Margin -56.6% EBITDA Mgn -31.4% EBITDA Mgn
Net Cash / Leverage $101.27 Book/Sh · 0.0% ROE $1855.16 Book/Sh · -19.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat WOK
OpEx & R&D Intensity 42.4% of Rev ($2.1M) 58.7% of Rev ($6.3M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Electrical Equipment & Parts Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ELPW (5) vs WOK (2)
Institutional Metric ELPW WOK Criterion Row Edge
Market Capitalization
Scale
$2.8M $5.4M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+14977.5% +19.1% Higher Growth ELPW
Operating Margin (TTM)
Profitability
-40.6% -41.7% Higher Margin ELPW
Net Profit Margin
Profitability
356.3% -41.9% Higher Margin ELPW
Return on Equity (ROE)
Capital Efficiency
0.0% -19.2% Higher ROE ELPW
52-Week Range Position
Momentum
6% ($0–$15) 16% ($0–$7) Stronger Trend WOK
Beta / 30D Volatility
Risk Regime
-70.48β · 220% Vol 38.49β · 153% Vol Lower Realized Risk WOK
Unified Institutional Score
Composite Signal
50.4 / 100 (HOLD) 25.6 / 100 (SELL) Higher Composite ELPW
Trailing 12M Revenue (USD)
Operating Scale
$4.9M $11M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
1.8% 17.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.6x EV/Rev N/M PEG · 0.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$2.8M EBITDA ($101.27 Book/Sh · 0.0% ROE) -$3.4M EBITDA ($1855.16 Book/Sh · -19.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon WOK +72.92 pp
ELPW: -60.08% · WOK: +12.84%
3M Horizon WOK +32.45 pp
ELPW: -76.54% · WOK: -44.09%
6M Horizon WOK +230.39 pp
ELPW: -6.71% · WOK: +223.68%
1Y Horizon ELPW +389.34 pp
ELPW: +317.29% · WOK: -72.05%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELPW vs WOK. Trailing 12-month operating profitability (ELPW -40.6% vs WOK -41.7%) and valuation multiples (ELPW N/M vs WOK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ELPW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.9M
Gross Margin1.8%
Op. Margin-40.6%
ROE / Fwd P/E0.0% · N/M
WOK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$11M
Gross Margin17.0%
Op. Margin-41.7%
ROE / Fwd P/E-19.2% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ELPW UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ELPW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
WOK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WOK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ELPW Moat Profile Cyclical / Execution-Driven Positioning
Electrical Equipment & Parts Operator
Competes within the Electrical Equipment & Parts value chain with $2.8M market capitalization and -40.6% operating margin.
OpEx & R&D Reinvestment 42.4% of Rev ($2.1M)
90D Engineering Disclosures 0 Published
WOK Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $5.4M market capitalization and -41.7% operating margin.
OpEx & R&D Reinvestment 58.7% of Rev ($6.3M)
90D Engineering Disclosures 0 Published

Investor FAQ ELPW vs WOK Key Questions & Quantitative Answers

As of Nov 16, 2026, Elong Power Holding Limited Class A (ELPW) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). ELPW carries a Unified Composite Score of 50.4/100 (HOLD) at $0.91 (N/M Forward P/E, -40.6% operating margin), whereas WOK carries 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin). Technical & Structure Timing Caution: ELPW is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.0); meanwhile WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ELPW leads the Growth & Scale pillar: ELPW posts +14977.5% YoY revenue growth and +0.0% YoY earnings growth on $4.9M TTM revenue (1.8% gross margin, -40.6% operating margin), compared with WOK at +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin). On trailing 12-month operating scale, ELPW generates $4.9M in USD-normalized revenue versus $11M for WOK. In operating R&D and SG&A reinvestment, ELPW deploys 42.4% of Rev ($2.1M) (0 90-day corporate R&D disclosures) versus 58.7% of Rev ($6.3M) (0 disclosures) for WOK.

ELPW and WOK trade at balanced relative valuation multiples. ELPW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-56.6% EBITDA margin), whereas WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELPW (0.0% ROE) versus WOK (-19.2% ROE) capital efficiency.

In options market volatility and institutional positioning, ELPW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-70.48β · 220% Vol realized risk). By comparison, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Elong Power Holding Limited Class A Ordinary Shares (ELPW) Research Suite

WORK Medical Technology Group LTD Class A Ordinary Shares (WOK) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.